Etter, Manina M. http://orcid.org/0000-0002-2889-8305
Martins, Tomás A. http://orcid.org/0000-0001-6016-2288
Kulsvehagen, Laila http://orcid.org/0000-0001-5236-8323
Pössnecker, Elisabeth http://orcid.org/0000-0002-6271-2404
Duchemin, Wandrille
Hogan, Sabrina
Sanabria-Diaz, Gretel
Müller, Jannis http://orcid.org/0000-0003-1394-8231
Chiappini, Alessio
Rychen, Jonathan
Eberhard, Noëmi
Guzman, Raphael
Mariani, Luigi
Melie-Garcia, Lester
Keller, Emanuela
Jelcic, Ilijas http://orcid.org/0000-0003-3090-7319
Pargger, Hans http://orcid.org/0000-0002-1234-7568
Siegemund, Martin http://orcid.org/0000-0002-2013-4140
Kuhle, Jens
Oechtering, Johanna
Eich, Caroline
Tzankov, Alexandar http://orcid.org/0000-0002-1100-3819
Matter, Matthias S. http://orcid.org/0000-0002-2005-5266
Uzun, Sarp
Yaldizli, Özgür
Lieb, Johanna M. http://orcid.org/0000-0002-9407-6473
Psychogios, Marios-Nikos
Leuzinger, Karoline http://orcid.org/0000-0002-5654-9356
Hirsch, Hans H.
Granziera, Cristina
Pröbstel, Anne-Katrin http://orcid.org/0000-0002-7748-1872
Hutter, Gregor http://orcid.org/0000-0002-7570-3902
Funding for this research was provided by:
Fondation Botnar (FTC_14052020)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (4078P0_198345)
Article History
Received: 22 February 2022
Accepted: 12 October 2022
First Online: 9 November 2022
Competing interests
: I.J. has received speaker honoraria or unrestricted grants from Biogen Idec and Novartis and has served as an advisor for Alexion, Biogen, Bristol Myers Squibb, Celgene, Janssen-Cilag, Neuway, Merck, Novartis, Roche and Sanofi Genzyme; none of these are related to this study. G.H. has equity in and is a co-founder of Incephalo Inc. A-K.P. has received speaker honoraria or research/travel support from Roche and Biogen all used for research. The remaining authors declare no competing interests.